The Value of Perfusion Fluid Culture Analysis in Deceased Donor Renal Transplants: A 10-Year Single-Center Experience.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Historique:
received: 28 09 2020
revised: 06 02 2021
accepted: 10 03 2021
pubmed: 9 5 2021
medline: 21 10 2021
entrez: 8 5 2021
Statut: ppublish

Résumé

Microbiological analysis of kidney perfusion/transport solution is not routinely performed in all transplant centers. This paper gives a 10-year descriptive single-center experience of the routine culture of perfusion fluid in deceased donor renal transplant recipients as well as the prophylactic treatment of certain organisms if identified. Data were collected retrospectively on all deceased donor transplants performed between 2009 and 2018. Organisms detected were classified as either pathologic, of uncertain pathogenicity, or contaminants. Treatment was guided by the microbiology team. A total of 661 specimens were analyzed. Organisms were cultured in 168 of 661 (25.4%) of these samples. The most frequent organisms identified were skin and oral flora (n = 95, 42%). The majority of organisms identified (131 of 226, 58%) necessitated prophylactic treatment on the advice of our microbiology department. On 7 (4.2%) occasions, the perfusion fluid cultures grew organisms not covered by the routine antimicrobial prophylaxis, and on 15 occasions Candida albicans was isolated. Candida isolates were treated preemptively with 1 month of antifungal treatment. There were no infective sequelae in this group.

Identifiants

pubmed: 33962779
pii: S0041-1345(21)00214-1
doi: 10.1016/j.transproceed.2021.03.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1808-1812

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Ammar Al Midani (A)

Royal Free London NHS Foundation Trust, Kidney and Urology, London, UK.

Lauren Hookham (L)

Royal Free London NHS Foundation Trust, Kidney and Urology, London, UK. Electronic address: l.hookham@nhs.net.

Neal Banga (N)

Royal Free London NHS Foundation Trust, Kidney and Urology, London, UK.

Gareth Jones (G)

Royal Free London NHS Foundation Trust, Kidney and Urology, London, UK.

Sophie Collier (S)

Royal Free London NHS Foundation Trust, Microbiology, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH